Correspondence

Jacob KS. The use of multiple psychotropic medication in the treatment of mental disorders. Australian and New Zealand Journal of Psychiatry 1995; 29:186–188.

Lam TP. Why should we prevent polypharmacy? The Hong Kong Practitioners 1995; 17:345–346.

Good BJ. Culture, diagnosis and comorbidity. Culture, Medicine and Psychiatry 1993; 16:427–446.

Kirmayer LJ. The place of culture in psychiatric nosology: Taijin kyofusho and DSM-III-R. Journal of Nervous and Mental Disease 1991; 179:19–28.

Michel K Kolanowska T. A survey of prescribing psychotropic drugs in two psychiatric hospitals. British Journal of Psychiatry 1981; 138:217–221.

Muijen M Silverstone T. A comparative hospital survey of psychotropic drug. British Journal of Psychiatry 1987; 144:501–504.

Diamond H Tislow R Snyder T Richels K. Peer review of prescribing patterns in CHMC. American Journal of Psychiatry 1976; 133:697–699.

Khanna R Bhandari SN Das A. Survey of psychotropic drug prescribing pattern for long stay patients. Indian Journal of Psychiatry 1990; 32:162–165.

Kendell RE. The role of diagnosis in psychiatry. Oxford: Blackwell, 1975.

Bergen J. Brief comment on: Jacob KS. The use of multiple psychotropic drugs in the treatment of mental disorders. Australian and New Zealand Journal of Psychiatry 1995; 29: 189.

Clark AF Holden NL. The persistence of prescribing patterns: a survey and follow up of prescribing to chronic hospital patients. British Journal of Psychiatry 1987; 150:88–91.

Anderson DN. A comparison of inpatient and outpatient prescribing. British Journal of Psychiatry 1989; 154:644–649.

Morgan R Gopalaswamy AK. Psychotropic drugs: another survey of prescribing patterns. British Journal of Psychiatry 1984; 144:298–302.

Goodwin FK. Psychiatry. Journal of the American Medical Association 1994; 271:1707–1708.

Kiessling LS Marcotte AC Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993; 92:39–43.

Swedo S Leonard H Kiessling M. Speculations on anti-neuronal antibody mediated neuropsychiatric disorders of childhood. Pediatrics 1994; 93:323–326.

Swedo SE Leonard HL Schapiro MB Casey BJ Mannheim GB Lenane MC Rettew DC. Sydenham's chorea: physical and psychological symptoms of St Vitus’ dance. Pediatrics 1993; 91:706–713.

Cavallo MG Baroni MG Toto A Gearing AJ Forsey T Andreani D Thorpe R Pozzilli P. Viral infection induces cytokine release by beta islet cells. Immunology 1992; 75:664–668.

Pearce BD Hobbs MV McGraw TS Buchmeier MJ. Cytokine induction during Tcell-mediated clearance of mouse hepatitis virus from neurons in vivo. Journal of Virology 1994; 68:5483–5495.

Byerley LO Alcock NW Starnes HF Jr Sepsis-induced cascade of cytokine mRNA expression: correlation with metabolic changes. American Journal of Physiology 1992; 262:E728–735.

Vara E Arias-Diaz J Garcia C Balibrea JL. Cytokine-induced inhibition of lipid synthesis and hormone secretion by isolated human islets. Pancreas 1994; 9:316–323.

Ciampolillo A Guastamacchia E Caragiulo L Lollino G De-Robertis O Lattanzi V Giorgino R. In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients. Diabetes Research and Clinical Practice 1993; 21: 87–93.

Suarez-Pinzon WL Strynadka K Schulz R Rabinovitch A. Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology 1994; 134:1006–1010.

Jobe LW Vertrees S Wilson CA Jacobs C Wilson DL Picha KS Baker P Lernmark A. In vivo effects of interleukin-1 beta on blood leukocytes in BB rats prone or resistant to diabetes. Autoimmunity 1992; 11:233–237.

Katila H Appelberg B Hurme M Rimon R. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophrenia Research 1994; 12:29–34.

Maes M Meltzer HY Bosmans E. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatrica Scandinavica 1994; 89:346–351.

Ganguli R Yang Z Shurin G Chengappa KN Brar JS Gubbi AV Rabin BS. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Research 1994; 51:1–10.

Shintani F Kanba S Maruo N Nakaki T Nibuya M Suzuki E Kinoshita N Yagi G. Serum interleukin-6 in schizophrenic patients. Life Science 1991; 49:661–664.

Biederman J Faraone SV Spencer T Wilens T Norman D Lapey KA Mick E Lehman BK Doyle A. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 1993; 150:1792–1798.

Buchsbaum MS. Functional imaging of the brain in psychiatry: positron emission tomography and blood flow studies. In: Berger PA Brodie KH , eds. American handbook of psychiatry. Vol 8. New York: Basic Books, 1986:236–248.

Eizirik DL Sandler S Welsh N Cetkovic-Cvrlje M Nieman A Geller DA Pipeleers DG Bendtzen K Hellerstrom C. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. Journal of Clinical Investigation 1994; 93:1968–1974.

Jhala U Baly DL. Effect of chronic IL-1 beta infusion on glucose homeostasis and pancreatic insulin secretion. Life Sciences 1994; 54:413–422.

Ohno Y Aoki N Nishimura A. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1993; 77:1072–1077.

Hotamisligil GS Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994; 43:1271–1278.

Hotamisligil GS Budavari A Murray D Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor alpha. Journal of Clinical Investigation 1994; 94:1543–1549.

Brekke OL Espevik T Bardal T Bjerve KS. Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytotoxicity in WEHI fibrosarcoma cells. Lipids 1992; 27:161–168.

Borkman M Storlein LH Pan DA Jenkins AB Chisholm DJ Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. New England Journal of Medicine 1993; 328:238–244.

Storlein LH Borkman M Jenkins AB Campbell LV. Diet and in vivo insulin action: of rats and man. Diabetes, Nutrition and Metabolism 1991; 4:227–240.

Mauduit C Jaspar JM Poncelet E Charlet C Revol A Franchimont P Benahmed M. Tumor necrosis factor-alpha antagonizes follicle-stimulating hormone action in cultured Sertoli cells. Endocrinology 1993; 133:69–76.

Best CL Pudney J Anderson DJ Hill JA. Modulation of human granulosa cell steroid production in vitro by tumor necrosis factor alpha: implications of white blood cells in culture. Obstetrics and Gynaecology 1994; 84:121–127.

Horrobin DF Manku MS Hillman H Glen AI Glen M. Fatty acid levels in the brains of schizophrenics and normal controls. Biological Psychiatry 1991; 30:795–805.

Horrobin DF. The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids 1992; 46:71–77.

Iacono WG Beiser M. Are males more likely than females to develop schizophrenia? American Journal of Psychiatry 1992; 149:1070–1074.

Pearlson G Pulver AE. Sex, schizophrenia and the cerebral cortex. In: Ancill RJ Holliday S Higenbottam J , eds. Schizophrenia: exploring the spectrum of psychosis. New York: Wiley, 1994:345–362.

Hallonquist JD Seeman MV Lang M Rector NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biological Psychiatry 1993; 33:207–209.

Checkley SA Wieck A Marks M Kumar R Beam JA Campbell I. Neuroendocrine studies of aetiology of puerperal psychosis. Clinical Neuropharmacology 1992; 15(Suppl): 212A–213A.

Seeman MV Lang M. The role of oestrogens in schizophrenia gender differences. Schizophrenia Bulletin 1990; 16:185–194.

De M Sanford TR Wood GW. Interleukin-1, interleukin-6, and tumor necrosis factor alpha are produced in the mouse uterus during the oestrous cycle and are induced by oestrogen and progesterone. Developmental Biology 1992; 151:297–305.

Kaplan R. Correspondence. False memory syndrome. Australian and New Zealand Journal of Psychiatry 1995; 29:516–517.

Taylor AT. Catatonia: a review of a behavioural neurological syndrome. Neuropsychiatry, Neuropsychology and Behavioural Neurology 1990; 3: 48.

Gelenberg AJ Mandel MR Catatonic reaction to high-potency neuroleptic drugs. Archives of General Psychiatry 1977; 34:947–950.

Fink M. Is catatonia a primary indication for ECT? Convulsive Therapy 1990; 6:1–4.

Fricchione G. Catatonia: a new indication for benzodiazepine. Biological Psychiatry 1989; 26:761–765.

Rosebush PI Hildebrand AM Furlong BG Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. Journal of Clinical Psychiatry 1990; 51:357–362.

Yassa R Iskandar H Lalines M Cleto L. Lorazepam as an adjunct in the treatment of catatonic states: an open clinical trial. Journal of Clinical Psychopharmacology 1990; 10:66–68.

Ungvari GS Leung CM Wong MK Lau J. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatrica Scandinavica 1994; 89:28:288.

Lee WYJ. Catatonia: the tension insanity. British Journal of Psychiatry 1993; 163:696. Published erratum appears in British Journal of Psychiatry 1994; 164:1341.

Salam SA Pillai AK Beresford TP. Lorazepam for psychogenic catatonia. American Journal of Psychiatry 1987; 144:1082–1083.

Smith S. Neuroleptic-associated hyperprolactinemia. Journal of Reproductive Medicine 1992; 37:737–740.

Anand VS. Clomipramine induced galactorrhea and amenorrhea. British Journal of Psychiatry 1985; 147:87–88.

Bronzo MR Stahl SM. Galactorrhea induced by sertraline. American Journal of Psychiatry 1994; 150: 1269–1270.

Meltzer HY Young M Melz J Fang VS Schyve PM Arora RC. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. Journal of Neural Transmission 1979; 45:165–175.

Lewis DA Sherman M. Serotoninergic regulation of prolactin and growth hormone secretion in man. Acta Endocrinologica 1985; 110:152–157.

Urban RJ Veldhuis JD. A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in post menopausal women. American Journal of Obstetrics and Gynaecology 1991; 164:147–152.

Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. British Journal of Psychiatry 1994; 165:728–733.

Pascual-Leone A Safety of rapid-rate transcranial magnetic stimulation in normal volunteers. Electroencephalography and Clinical Neurophysiology 1993; 89:120–130.

Pascual-Leone A Resetting of essential tremor and postural tremor in Parkinson's Disease with transcranial magnetic stimulation. Muscle and Nerve 1994; 17:800–807.

Pascual-Leone A Lasting beneficial effect of rapid-rate transcranial magnetic stimulation on slowness in Parkinson's disease (PD) [abstract]. 4. Neurology 1995; 45(suppl. 4):A315.

Pascual-Leone A Hallett M. Induction of errors in a delayed response task by repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex. Neuroreport 1994; 5:2517–2520.

Catala M Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood [abstract]. Neurology 1995; 45(Suppl 4):A389.

Williams W Rapid Transcranial Magnetic Stimulation (rTMS) in prefrontal cortex: mood and neuroendocrine effects [abstract]. Neurology 1995; 45(suppl. 4):A178.

Hoflich G Application of transcranial magnetic stimulation in treatment of drug-resistant major depression — a report of two cases. Human Psychopharmacology 1993; 8:361–365.

Effects of newspaper stories on the incidence of suicide in Australia: a research note. Australian and New Zealand Journal of Psychiatry 1995; 29:480–483.